Larry A. Harshyne

Larry A. Harshyne serves as Assistant Professor in the Department of Microbiology & Immunology at Thomas Jefferson University's College of Life Sciences, focusing on glioma-immune system interactions and dendritic cell-based vaccine development.

His core research domains include:

• Glioma-Immune Evasion Mechanisms: Investigating how brain tumors suppress anti-tumor immune responses
• Dendritic Cell Vaccine Engineering: Loading tumor antigens ex vivo to reactivate lymphocyte responses against gliomas
• Tumor Microenvironment Dynamics: Analyzing immunosuppressive landscapes in head/neck cancers
• Neoadjuvant Immunotherapy Optimization: Studying surgical timing and biomarker correlations for treatment enhancement

Publication analysis reveals concentrated expertise in computational modeling of immunotherapy outcomes, biomaterial-immune cell interactions, and age-specific tumor microenvironment alterations. His work bridges fundamental immunology with clinical oncology applications through tumor antigen presentation strategies.

Dr. Harshyne directs a research group advancing dendritic cell vaccination protocols while exploring macrophage polarization in tissue engineering contexts, with ongoing investigations into extracellular matrix remodeling and immune checkpoint inhibitor responses.